Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Timothy M. Janetos"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The COVID-19 pandemic has led to both intentional and unintentional care delay among age-related neovascular macular degeneration (nvAMD) patients. Prior studies have demonstrated that patients who discontinue nvAMD treatment for prolonged i
Externí odkaz:
https://doaj.org/article/6fe0829332d24be88846101c2255389c
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 32, Iss , Pp 101896- (2023)
Purpose: Presumed ocular histoplasmosis syndrome (POHS) is a posterior segment disorder that is usually subclinical unless choroidal neovascular membrane (CNVM) develops. It is thought to be the sequela of a prior systemic infection with Histoplasma
Externí odkaz:
https://doaj.org/article/a46bd7d59137406fb5f222b91126985f
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)
Abstract Background A central retinal artery occlusion (CRAO) is an ophthalmic emergency due to its strong association with cerebrovascular and cardiovascular morbidity and mortality. A timely diagnosis is necessary but difficult in the setting of de
Externí odkaz:
https://doaj.org/article/215973fde25d47e8ae059d5b99a64b87
Autor:
Henry S. Bison, Timothy M. Janetos, Hans M. Gao, David L. Zhang, Jessica Song, Brenda L. Bohnsack
Publikováno v:
American Journal of Ophthalmology. 247:70-78
To determine uveitis incidence in juvenile idiopathic arthritis (JIA) patients treated with disease-modifying antirheumatic drugs (DMARD) medications, and to evaluate uveitis risk-stratification protocols.Retrospective clinical cohort study.Medical r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19283da911fbc7306dce918c1ba9a3f8
https://doi.org/10.1016/j.ajo.2022.11.010
https://doi.org/10.1016/j.ajo.2022.11.010
Publikováno v:
The American Journal of Pathology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5190cb7d642177e8c4a7b5cf549cfe22
https://doi.org/10.1016/j.ajpath.2023.03.004
https://doi.org/10.1016/j.ajpath.2023.03.004
Autor:
Aaron R. Kaufman, Shawn Gulati, John H. Pula, Timothy M. Janetos, Neena R. Cherayil, Eric Chiu, Emily Anne Shepherd, Karl C. Golnik, Enrique Garcia-Valenzuela, Peter W. MacIntosh, Brooke T. Johnson, Kimberlee M. Curnyn
Publikováno v:
Journal of Neuro-Ophthalmology. 42:530-534
Topical glycopyrronium tosylate (GT) is an anticholinergic medication for treatment of axillary hyperhidrosis. Pharmacologic mydriasis and anisocoria from topical GT has been reported and may be underrecognized. This study aims to clinically characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba01a49923258b098740d1edfbb747e7
https://doi.org/10.1097/wno.0000000000001567
https://doi.org/10.1097/wno.0000000000001567
Autor:
Ruifang, Zeng, Wenzhuo, Zhu, Li, Jiang, Xi, Zhu, Yan, Gao, Yi, Xia, Bing, Bai, Naoto, Shikama, Timothy M, Janetos, Samir, Dalia, Onder, Alpdogan, Xiaoxiao, Wang, Lingling, Zhu, Pengfei, Li
Publikováno v:
Annals of translational medicine. 10(20)
Lymphopenia at diagnosis is considered a negative prognostic factor for patients with extra-nodal natural killer (NK)/T-cell lymphoma (ENKTL), especially that of the absolute cluster of differentiation 4We analyzed the clinical data of 176 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cdc28fe6b72adb17903f03f6d848bee
https://pubmed.ncbi.nlm.nih.gov/36388826
https://pubmed.ncbi.nlm.nih.gov/36388826
Autor:
Timothy M. Janetos, Ajay Bhasin
Publikováno v:
Journal of General Internal Medicine. 38:234-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d737fdcf515d67acf2888ff7ef932a0
https://doi.org/10.1007/s11606-022-07853-2
https://doi.org/10.1007/s11606-022-07853-2
Autor:
David Gu, Timothy M. Janetos
Publikováno v:
Ophthalmic Epidemiology. 28:21-26
Pharmaceutical development has slowed since the turn of the century and there has been recent legislation passed that aims to accelerate drug approval. Ophthalmic drug discovery has unique challenges that may benefit from these legislative changes. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ca8d4ef8e92d75691c9f6688a9b85f
https://doi.org/10.1080/09286586.2020.1786591
https://doi.org/10.1080/09286586.2020.1786591
Autor:
Ruifang Zeng, Wenzhuo Zhu, Li Jiang, Xi Zhu, Yan Gao, Yi Xia, Bing Bai, Naoto Shikama, Timothy M. Janetos, Samir Dalia, Onder Alpdogan, Xiaoxiao Wang, Lingling Zhu, Pengfei Li
Publikováno v:
Annals of Translational Medicine. 10:1119-1119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73963b7bfb58a99a487690adde683b44
https://doi.org/10.21037/atm-22-4846
https://doi.org/10.21037/atm-22-4846